Covaxin Who Approval

The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.

Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."

Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.

Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.

China and India's Covid vaccines have been approved by the U.K. for travel into the country, clearing the way for tourists and foreign students who have been fully immunized with them to enter.

The World Health Organization's (WHO) approval to Covaxin vaccine earlier this month would bring about a significant improvement in the ease of travel for vaccinated Indians, the Ministry of External Affairs said.

Union Health Minister Mansukh Mandaviya said on Tuesday that 96 countries have recognised Covaxin and Covishield and both these COVID-19 vaccines have received emergency use listing (EUL) from the World Health Organisation (WHO).

External Affairs Minister S Jaishankar on Wednesday said the WHO''s decision to grant emergency use approval to Bharat Biotech''s COVID-19 vaccine Covaxin facilitates travel for many Indian citizens and contributes to vaccine equity.

Covaxin, by no means, took the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, Chief Scientist Dr Soumya Swaminathan said today

The clearance for using Covaxin on children will take much less time, World Health Organization (WHO) chief scientist Dr Soumya Swaminathan told NDTV after the Bharat Biotech-manufactured vaccine's Emergency Use Listing.

The Emergency Use Listing nod to Bharat Biotech's Covaxin, which was found to have 78 per cent efficacy against COVID-19 of any severity, expands the availability of vaccines, the most effective medical tools to end the pandemic, a WHO official said

World Health Organisation Director-General Tedros Adhanom Ghebreyesus on Wednesday said he is "glad" to see Covaxin get the Emergency Use Listing approval.

The World Health organisation's approval of Covaxin will expedite global access and availability of the first India-made vaccine against coronavirus worldwide, its manufacturer Bharat Biotech said in a statement.

WHO on Wednesday "granted Covaxin an Emergency Use Listing (EUL)".

The WHO has granted Covaxin an emergency use listing, sources said Wednesday, which means the 'made-in-India' vaccine will be recognised by other countries and Indians who received the shot need not self-quarantine or face restrictions abroad.

The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.

Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."

Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.

Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin.

China and India's Covid vaccines have been approved by the U.K. for travel into the country, clearing the way for tourists and foreign students who have been fully immunized with them to enter.

The World Health Organization's (WHO) approval to Covaxin vaccine earlier this month would bring about a significant improvement in the ease of travel for vaccinated Indians, the Ministry of External Affairs said.

Union Health Minister Mansukh Mandaviya said on Tuesday that 96 countries have recognised Covaxin and Covishield and both these COVID-19 vaccines have received emergency use listing (EUL) from the World Health Organisation (WHO).

External Affairs Minister S Jaishankar on Wednesday said the WHO''s decision to grant emergency use approval to Bharat Biotech''s COVID-19 vaccine Covaxin facilitates travel for many Indian citizens and contributes to vaccine equity.

Covaxin, by no means, took the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, Chief Scientist Dr Soumya Swaminathan said today

The clearance for using Covaxin on children will take much less time, World Health Organization (WHO) chief scientist Dr Soumya Swaminathan told NDTV after the Bharat Biotech-manufactured vaccine's Emergency Use Listing.

The Emergency Use Listing nod to Bharat Biotech's Covaxin, which was found to have 78 per cent efficacy against COVID-19 of any severity, expands the availability of vaccines, the most effective medical tools to end the pandemic, a WHO official said

World Health Organisation Director-General Tedros Adhanom Ghebreyesus on Wednesday said he is "glad" to see Covaxin get the Emergency Use Listing approval.

The World Health organisation's approval of Covaxin will expedite global access and availability of the first India-made vaccine against coronavirus worldwide, its manufacturer Bharat Biotech said in a statement.

WHO on Wednesday "granted Covaxin an Emergency Use Listing (EUL)".

The WHO has granted Covaxin an emergency use listing, sources said Wednesday, which means the 'made-in-India' vaccine will be recognised by other countries and Indians who received the shot need not self-quarantine or face restrictions abroad.